TaqMan PCR assay in the control of RNA normalization in human post-mortem brain tissue.
Barrachina M, Castaño E, Ferrer I
Purpose
The purpose of this paper was to evaluate the predictive value of agonal state, postmortem interval (PMI), and brain pH on the quality of RNA extracted from postmortem frontal cortex. Several transcripts were evaluated for their utility in serving as endogenous control genes for the normalization of superoxide dismutase 1 (SOD1) and metalloproteinase domain 22 (ADAM22) levels.
Conclusion
Age at death, agonal state, PMI (5-25 h), and brain pH (6.2-6.75) were not correlated to RNA quality and were, therefore, poor predictors of RNA degradation. GUS was identified by the authors as a favorable candidate for normalization due to its stable and homogenous expression across PMI (up to 25 h), disease states, and its resistance to degradation.
Studies (2)
Purpose
The purpose of this study was to compare two methods of RNA evaluation in the context of patient age, agonal state, brain pH, and postmortem interval.
Summary of Findings
The authors report that electropherograms generated with the Agilent bioanalyzer were more sensitive in detecting RNA degradation than was conventional electrophoresis. No correlation was seen between RNA degradation and patient age, agonal state, brain pH, or postmortem interval.
Biospecimens
TissueBrainPreservation Types
FrozenDiagnoses
Not specifiedParkinson's DiseaseLewy Body DiseaseAlzheimer's DiseaseAutopsyPlatforms
RNASpectrophotometryRNAElectrophoresisRNAAutomated electrophoresis/BioanalyzerPre-analytical Factors
Classification Pre-Analytical Factor Value(s) Preaquisition Diagnosis/ patient condition Age-matched controlAlzheimer's diseaseDementia with Lewy bodies, common formDementia with Lewy bodies, pure formParkinson's diseasePreaquisition Patient age 55 - 91 yearsPreaquisition Postmortem interval 10 h12 h13 h2 h3 h4 h5 h6 h7 h8 hBiospecimen Aliquots and Components pH Brain pH 6.11 - 7.02
Purpose
The purpose of this study was to assess several candidate control genes for normalization of RNA degradation in real-time quantitative reverse transcriptase polymerase chain reaction (qRT-PCR): human acidic ribosomal protein, beta-actin, cyclophilin, glyceraldehyde-3-phosphate dehydrogenase, phosphoglycerokinase, beta-2-microglobulin, beta-glucoronidase (GUS), hypoxanthine phosphoribosyltransferase, transcriptin factor IID TATA binding protein, and transferrin receptor. These potential control genes were compared to SOD1 and AMAD22 at a variety of postmortem intervals.
Summary of Findings
While GUS and beta-actin were identified as candidate genes for normalization of qRT-PCR expression results to assess candidate gene degradation, GUS outperformed beta-actin with regards to inter-sample variability, stability with increasing PMI (beta-actin degradation was observed after 25 h), and susceptibility to degradation, although both genes did not vary among disease states.
Biospecimens
TissueBrainPreservation Types
FrozenDiagnoses
Parkinson's DiseaseLewy Body DiseaseAlzheimer's DiseaseNot specifiedAutopsyPlatforms
RNAReal-time qRT-PCRPre-analytical Factors
Classification Pre-Analytical Factor Value(s) Preaquisition Postmortem interval 25 h5 h9 hPlatform-specific Methodology Targeted nucleic acid Beta-2-microglobulinBeta-actinBeta-glucoronidaseCyclophilinGlyceraldehyde-3-phosphate dehydrogenaseHuman acidic ribosomal proteinHypoxanthine phosphoribosyltransferasePhosphoglycerokinaseTranscriptin factor IID TATA binding proteinTransferrin receptor